-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Dx62h7sca/Xzl/hn6V+875Gz1fxurFB1ODjNa9LT6tsfvyUOWLSQcyfg+hOnUXhw YE0wcane1reqWGVfqfbHNQ== 0000200406-07-000047.txt : 20070221 0000200406-07-000047.hdr.sgml : 20070221 20070221184409 ACCESSION NUMBER: 0000200406-07-000047 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070216 FILED AS OF DATE: 20070221 DATE AS OF CHANGE: 20070221 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOGGINS COLLEEN A CENTRAL INDEX KEY: 0001189008 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 07640064 BUSINESS ADDRESS: BUSINESS PHONE: 732 524 2455 MAIL ADDRESS: STREET 1: C/O JOHNSON & JOHNSON STREET 2: ONE JOHNSON PLAZA CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2007-02-16 0000200406 JOHNSON & JOHNSON JNJ 0001189008 GOGGINS COLLEEN A JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 0 1 0 0 Member, Executive Committee Common 2007-02-16 4 M 0 1300 32.38 A 91906 D Common 2007-02-16 4 F 0 639 65.79 D 91267 D Common 1074 I 401(k) and ESOP Savings Plans Phantom Stock Units 2007-02-16 4 A 0 2024 0 A Common Stock 2024 10544 D Employee Stock Option (Right to Buy) 32.38 2007-02-16 4 M 0 1300 0 D 2000-12-04 2007-12-03 Common Stock 1300 0 D Adjusted to reflect two-for-one stock split in 2001. Shares held under Johnson & Johnson's 401(k) and ESOP Savings Plans as of Plans' most recent reporting date (01/31/2007). The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on February 16, 2007 at $65.49 per share are to be settled in cash upon the Reporting Person's Retirement. The Phantom Stock converts into common stock on a one-for-one basis. Awarded under Issuer's Stock Option Plan and exercisable in full starting three years from date of grant. Linda E. King, Attorney-in-Fact for Colleen A. Goggins 2007-02-21 -----END PRIVACY-ENHANCED MESSAGE-----